title: Cutaneous field cancerization: clinical, histopathological and therapeutic aspects.
abstract: The concept of "field cancerization" was first introduced by Slaughter in 1953 when studying the presence of histologically abnormal tissue surrounding oral squamous cell carcinoma. It was proposed to explain the development of multiple primary tumors and locally recurrent cancer. Organ systems in which field cancerization has been described since then are: head and neck (oral cavity, oropharynx, and larynx), lung, vulva, esophagus, cervix, breast, skin, colon, and bladder. Recent molecular studies support the carcinogenesis model in which the development of a field with genetically altered cells plays a central role. An important clinical implication is that fields often remain after the surgery for the primary tumor and may lead to new cancers, designated presently as "a second primary tumor" or "local recurrence," depending on the exact site and time interval. In conclusion, the development of an expanding pre-neoplastic field appears to be a critical step in epithelial carcinogenesis with important clinical consequences. Diagnosis and treatment of epithelial cancers should not only be focused on the tumor but also on the field from which it developed. The most important etiopathogenetic, clinical, histopathological and therapeutic aspects of field cancerization are reviewed in this article.
authors.affiliation: Hospital das Clinicas, University of São Paulo Medical School, São PauloSP, Brazil.
authors.forename: Luís Antônio Ribeiro
authors.initials: LA
authors.lastname: Torezan
authors.forename: Cyro
authors.initials: C
authors.lastname: Festa-Neto
mesh_terms: D063646:Carcinogenesis; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D009378:Neoplasms, Multiple Primary; D012307:Risk Factors; D012878:Skin Neoplasms / Q000473:pathology* / Q000628:therapy*